Dyes, Pigments & Colorants Patents: Top Filers & Trends 2026
- 88.8% sits with five filers. The top five assignees account for 214 of the 241 records in scope — a field with a small leading group and a long tail of single-filing entrants.
- Filings fell -93% after 2021. From a peak of 59 records in 2021 to 4 in 2024, the most recent complete year — a sharp contraction in new claim activity on this exact search combination.
- Claims skew toward formulation, not pigment synthesis. 80.5% of records carry an A61K medicinal-preparations classification, versus under 6% for polymer-composition (C08L) claims.
Filing growth compares 2021 (59 records) with 2024 (4) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 241 records in scope (CR5), not by the ranked leaders only.
How this field is structured
Filing in this search combination is heavily concentrated: the top five assignees hold 88.8% of the 241 records in scope, and the ranking’s remaining companies each contribute a small, mostly single-digit share. The technology mix leans toward formulation and activity claims rather than classical dye or pigment synthesis, with A61K medicinal-preparations classifications present in four out of five records.
Filing activity rose sharply through the late 2010s, peaked in 2021 at 59 records, then contracted to 4 by 2024 — the last year that can be treated as a complete count given normal publication lag. That contraction, combined with the concentration at the top of the assignee ranking, points to a field where the core claim space around a small number of leading filers has already been substantially staked out.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing concentration and technology mix
241 published records sit in scope for this search across 2015 through the partial 2026 year. The assignee ranking and IPC composition below use that same 241-record denominator throughout.
Filing trend: a sharp rise, then a sharp fall
Filings climbed to a peak of 59 in 2021, then dropped to 4 by 2024 — a -93% move over that three-year span. 2025 and later years are still filling in because publication lags filing by roughly 18 months, so do not read the most recent bars as a decline in real filing activity.
Where the claims sit
A61K (medicinal preparations) covers 80.5% of the 241 records and A61P (therapeutic activity) 63.9%, showing this corpus is dominated by formulation and activity claims rather than classical pigment or dye synthesis. C08L (polymer compositions) and C07K (peptides & proteins) sit under 6% each, marking the thinnest-claimed branches in scope.
Shares are the percentage of the 241 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Dyes, Pigments & Colorants Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about dyes, pigments & colorants patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited record in this corpus
Microfluidic device with a cylindrical microchannel and a method for fabricating same
A method of manufacturing a microfluidic device having at least one cylindrical microchannel includes providing a substrate, casting an uncured polymer matrix solution onto the substrate, embedding an elongated rod in the uncured polymer matrix solution, curing the polymer matrix solution to form a solidified body, and extracting the elongated rod to form the cylindrical microchannel in the solidified body. A variant forms an optical feature on the device surface.Filed by Trustees of Tufts College, published 2010-03-18. Cited 115 times within this corpus, with its priority filing WO2008127405A2 close behind at 114.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO2019051380A1 | Bacterial extracellular vesicles | 118 |
| 2 | US20100068740A1 | Microfluidic device with a cylindrical microchannel and a method for fabricating same | 115 |
| 3 | WO2008127405A2 | Microfluidic device with a cylindrical microchannel and a method for fabricating same | 114 |
| 4 | WO2019051381A1 | Extracellular vesicles from prevotella | 49 |
| 5 | WO2020172492A2 | Bacterial membrane preparations | 27 |
| 6 | WO2019010255A1 | Compositions and methods of treating cancer using bifidobacterium animalis ssp. lactis | 26 |
| 7 | US20200254028A1 | Bacterial extracellular vesicles | 24 |
| 8 | US20140334005A1 | Signal enhancement by silk photonic crystals | 22 |
| 9 | WO2013130156A2 | Signal enhancement by silk photonic crystals | 22 |
| 10 | WO2019099482A1 | Compositions and methods for treating disease using a blautia strain | 21 |
Ranked by citation count within this search; older records accumulate more citations by nature of being searchable longer, so treat this as a signal of influence rather than current importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the filing pattern tells you
Three figures from this dataset matter more than the rest for anyone deciding where to file or where to look for freedom to operate.
A small leading group, then a long tail
The top five assignees combine for 214 of the 241 records in scope, and the top ten reach 93.8%. The remaining 22 ranked companies each hold a small share, so diligence effort is best spent on the leading group rather than spread evenly across the ranking.
A filing burst that has largely ended
Filings rose to a peak of 59 in 2021 and fell to 4 by 2024. Because publication lags filing by roughly 18 months, 2025 and later data points are still incomplete and should not be read as an ongoing decline — but the 2021-2024 trajectory itself is real.
Formulation claims dominate over pigment synthesis
A61K (medicinal preparations) and A61P (therapeutic activity) cover 80.5% and 63.9% of records respectively, while polymer-composition claims under C08L sit at only 3.7%. That gap marks where colorant-carrier formulation work remains lightly claimed.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to dyes, pigments & colorants patent landscape, with the prior art for and against each one.
Who holds the claim space, and where it thins out
32 companies and institutions make up the full assignee ranking behind this search. Activity is dominated by a small leading group, and recent-year momentum has gone flat across nearly every one of them — a pattern consistent with the 2021 filing peak having already passed.
One filer dominates the ranking
The leading assignee alone holds 198 of the 241 records in scope, dwarfing the fifth-place holder at 3 and tenth place at 2. Any competitive assessment of this field starts with understanding that single filer's portfolio in detail before looking at anyone else.
Recent-year activity has gone quiet
Every one of the leading assignees tracked for recent-year momentum shows zero filings in the latest year, including a -100% year-on-year change for the top filer. Combined with the 2021 peak and subsequent drop, this points to a claim space that filled quickly and then stopped.
Joint filing is rare
Only 9 co-assignee pairs appear across the entire dataset, and the strongest of them repeat the same lead assignee with different individual co-inventors. There is no dense collaborative network to navigate here — most filings are solo efforts.
| Assignee | Recent year | YoY |
|---|---|---|
| Evelo Biosciences, Inc. | 0 | -100% |
| Taya Canvas (Shanghai) Co., Ltd. | 0 | — |
| Tufts University | 0 | — |
| HODODI ANDREI | 0 | — |
| BiVictriX Ltd. | 0 | — |
| Trustees of Tufts College | 0 | — |
| ANDREI HODODI | 0 | — |
| Massachusetts Institute of Technology | 0 | — |
Where to take this analysis
The figures above describe where filing has concentrated and where it has thinned. Turning that into a filing or freedom-to-operate decision means going deeper on specific claims and specific assignees.
Check the leading assignee's full portfolio
With 198 of 241 records held by a single filer, understanding the exact claim scope of that portfolio is the first step before assessing where else to file.
Search assignee portfolios in EurekaTrack the post-2021 filing pattern as it fills in
2025 and later data points are still incomplete due to publication lag. Revisit the trend once another 12-18 months of publications have landed.
Set up filing alerts in EurekaMap the under-claimed polymer-carrier branch
C08L classifications sit at just 3.7% of records in scope. A targeted search on polymer-composition claims tied to colorant stability could surface open claim space.
Run a white space search in EurekaCommon questions on this landscape
The assignee ranking behind this search returns 32 companies and institutions, and it is heavily concentrated: the top five combined account for 88.8% of the 241 records in scope, and the top ten reach 93.8%. That means most of the activity sits with a small handful of filers, with the remainder made up of single-filing entrants rather than a broad competitive field. Anyone assessing freedom to operate should focus diligence on that small leading group first, since the long tail contributes comparatively little filing volume.
Filing volume in this exact search peaked in 2021 at 59 records and fell to 4 by 2024, a -93% change over that span, which is the most recent period that can be treated as complete data. Because publication typically lags filing by around 18 months, the years after 2024 are still filling in and should not be read as a genuine slowdown yet. The honest read is that the burst of activity around 2018-2021 has largely run its course on this specific claim combination, and it is too early to say whether a new wave is forming.
A61K, medicinal preparations, appears in 80.5% of the 241 records, and A61P, therapeutic activity of compounds, in 63.9%, meaning most claims are framed around formulation and biological activity rather than pigment or dye chemistry in the classical sense. Microorganism and genetic-engineering classifications (C12N, C12R) also show meaningful presence, at 27.0% and 10.4% respectively. Because a single record can carry several IPC classes, these figures add up to more than 100% and should not be read as mutually exclusive categories.
The thinnest classes in scope are C08L (polymer compositions) at 3.7% of the 241 records and C07K (peptides & proteins) at 5.8%, both well below the dominant A61K and A61P classes. That gap suggests formulation work tying a colorant or active compound to a specific polymer carrier, with a stated additive concentration or purity limitation, is claimed far less densely than the core preparation itself. Co-assignee filing is also thin across the whole dataset at only 9 pairs, so a new filer in these branches is unlikely to be competing against an entrenched joint-filing position.
US20100068740A1, assigned to Trustees of Tufts College and filed 2010-03-18, claims a specific method of building a cylindrical microchannel in a polymer body by casting an uncured polymer matrix, embedding a rod, curing, then extracting the rod, plus a variant adding an optical surface feature. With 115 citations, and its near-identical priority filing WO2008127405A2 at 114, it sits among the most-cited records in this corpus, indicating a large share of later fabrication-method filings build on this exact sequence. Design-arounds generally require a different channel-forming process, such as sacrificial-material dissolution or lithographic patterning, rather than rod embedding and extraction.
Research Dyes, Pigments & Colorants Patent Landscape in depth with Eureka
Go past this page: query the whole dyes, pigments & colorants patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.